| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 7 |
| 1 | OCTREOTIDE ACETATE | 6 |
| 2 | EVEROLIMUS | 4 |
| 3 | OMEPRAZOLE | 3 |
| 4 | OMEPRAZOLE MAGNESIUM | 3 |
| 5 | VEDOLIZUMAB | 3 |
| 6 | ALBUTEROL SULFATE | 2 |
| 7 | ATENOLOL | 2 |
| 8 | BEVACIZUMAB | 2 |
| 9 | BORTEZOMIB | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLOROTHIAZIDE SODIUM | 1 | 0.0011 |
| 1 | CHLOROTHIAZIDE | 1 | 0.0008 |
| 2 | ECALLANTIDE | 1 | 0.0005 |
| 3 | ALPROSTADIL | 1 | 0.0003 |
| 4 | OCTREOTIDE ACETATE | 6 | 0.0002 |
| 5 | CALCIUM CARBONATE, SIMETHICONE | 1 | 0.0002 |
| 6 | NORETHINDRONE | 1 | 0.0002 |
| 7 | BENAZEPRIL HYDROCHLORIDE | 1 | 0.0001 |
| 8 | REPAGLINIDE | 1 | 0.0001 |
| 9 | LANREOTIDE ACETATE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 1 | Glinide [EPC] | 1 | 0.0001 |
| 2 | Aluminum Complex [EPC] | 1 | 0.0000 |
| 3 | Integrin Receptor Antagonist [EPC] | 3 | 0.0000 |
| 4 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 5 | Folate Analog [EPC] | 1 | 0.0000 |
| 6 | Vitamin A [EPC] | 1 | 0.0000 |
| 7 | Proteasome Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Nicotinic Acid [EPC] | 1 | 0.0000 |
| 9 | Antidote [EPC] | 1 | 0.0000 |